| Teva Pharmaceutical Industries Ltd ADR (TEVA) | |||
|---|---|---|---|
| 11.03 0.34 (3.18%) | 08-08 16:00 | ||
| Open: | 10.86 | Pre. Close: | 10.69 |
| High: | 11.05 | Low: | 10.805 |
| Volume: | 20,185,751 | Market Cap: | 12,249M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 11.057 - 11.089 | 11.089 - 11.126 |
| Low: | 10.71 - 10.75 | 10.75 - 10.795 |
| Close: | 10.959 - 11.02 | 11.02 - 11.088 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 12.91  One year: 15.07 |
| Support: | Support1: 8.41 Support2: 6.78 |
| Resistance: | Resistance1: 11.05 Resistance2: 12.91 |
| Pivot: | 8.81 |
| Moving Averages: | MA(5): 10.33 MA(20): 8.36 MA(100): 8.54 MA(250): 8.71 |
| MACD: | MACD(12,26): 0.77 Signal(12,26,9): 0.42 |
| %K %D: | %K(14,3): 99.09 %D(3): 98.45 |
| RSI: | RSI(14): 81.97 |
| 52-Week: | High: 11.05 Low: 6.78 Change(%): 13.2 |
| Average Vol(K): | 3-Month: 13355 10-Days: 25756 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TEVA ] has closed below upper band by 10.6%. Bollinger Bands are 168.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—Specialty & Generic | |
| Shares Out. (M) | 1100.00 |
| Shares Float (M) | 1100.00 |
| % Held by Insiders | 1.50 |
| % Held by Institutions | 46.25 |
| Shares Short (K) | 17760 |
| Shares Short Prior Month (K) | 19380 |
| Stock Financials | |
|---|---|
| EPS | 0.660 |
| Book Value (p.s.) | 9.490 |
| Profit Margin | -6.83 |
| Operating Margin | 18.87 |
| Return on Assets (ttm) | 3.8 |
| Return on Equity (ttm) | -10.0 |
| Qtrly Rev. Growth | -3.2 |
| Gross Profit (p.s.) | 6.900 |
| Sales Per Share | 14.027 |
| EBITDA (p.s.) | 3.855 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 1060.00 |
| Levered Free Cash Flow (M) | 2540.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | 16.71 |
| PEG Ratio | |
| Price to Book value | 1.16 |
| Price to Sales | 0.79 |
| Price to Cash Flow | 11.45 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
